Table 1. Clinical characteristics of all participants according to BMI category.
BMI category |
Number of participants |
Sex men, n (%) |
Age, years | BMI, kg/m2 | Current smoker, n (%) |
Current drinker, n (%) |
SBP, mm Hg | DBP, mm Hg | TC, mg/dL | TG, mg/dL | Follow-up period, years |
Follow-up period, person-years |
Number of death |
Crude death rates, per 1,000 person-years |
<19 | 12,528 | 4,929 (39.3%) | 61.1 (11.2) | 17.9 (0.9) | 3,711 (29.6%) | 3,934 (31.7%) | 128.0 (20.1) | 75.0 (11.2) | 190.2 (34.3) | 82 (63–109) | 9.7 (3.5) | 121,054 | 2,243 | 18.5 (17.8–19.3) |
19.0–19.9 | 12,156 | 4,886 (40.2%) | 58.8 (11.0) | 19.5 (0.3) | 3,432 (28.2%) | 4,247 (34.9%) | 128.4 (18.9) | 75.7 (11.0) | 192.3 (35.5) | 87 (65–119) | 9.8 (3.3) | 119,235 | 1,470 | 12.3 (11.7–13.0) |
20.0–20.9 | 17,255 | 6,937 (40.2%) | 58.3 (10.8) | 20.5 (0.3) | 4,667 (27.0%) | 6,176 (36.1%) | 129.6 (19.2) | 76.5 (11.0) | 194.2 (34.9) | 93 (69–129) | 9.9 (3.2) | 170,979 | 1,854 | 10.8 (10.4–11.3) |
21.0–21.9 | 21,259 | 8,454 (39.8%) | 58.1 (10.6) | 21.5 (0.3) | 5,367 (25.2%) | 7,690 (36.5%) | 130.5 (18.7) | 77.3 (10.9) | 197.4 (35.6) | 100 (74–141) | 9.9 (3.1) | 210,811 | 1,916 | 9.1 (8.7–9.5) |
22.0–24.9 | 66,962 | 26,162 (39.2%) | 58.3 (10.1) | 23.4 (0.9) | 14,779 (22.1%) | 23,627 (35.5%) | 133.1 (18.4) | 79.1 (10.8) | 202.5 (35.7) | 117 (83–167) | 9.9 (3.0) | 661,424 | 5,593 | 8.5 (8.2–8.7) |
25.0–25.9 | 16,253 | 6,153 (37.9%) | 58.8 (9.8) | 25.5 (0.3) | 3,266 (20.1%) | 5,539 (34.3%) | 135.8 (17.9) | 80.9 (10.7) | 207.0 (35.6) | 135 (97–192) | 9.8 (2.9) | 159,439 | 1,286 | 8.1 (7.6–8.5) |
26.0–26.9 | 12,177 | 4,443 (36.5%) | 58.9 (9.8) | 26.5 (0.3) | 2,312 (19.0%) | 3,972 (32.9%) | 137.0 (18.1) | 81.9 (10.8) | 208.0 (35.7) | 141 (99–201) | 9.9 (2.9) | 120,071 | 986 | 8.2 (7.7–8.7) |
27.0–27.9 | 8,163 | 2,749 (33.7%) | 59.0 (9.7) | 27.5 (0.3) | 1,465 (17.9%) | 2,524 (31.2%) | 138.5 (17.9) | 82.7 (10.7) | 209.7 (35.7) | 145 (103–209) | 9.9 (2.9) | 80,407 | 675 | 8.4 (7.8–9.1) |
28.0–28.9 | 5,317 | 1,685 (31.7%) | 59.1 (9.7) | 28.5 (0.3) | 911 (17.1%) | 1,543 (29.3%) | 139.6 (18.3) | 83.6 (11.0) | 210.0 (35.9) | 151 (107–214) | 9.9 (2.9) | 52,451 | 431 | 8.2 (7.5–9.0) |
29.0–29.9 | 3,277 | 880 (26.9%) | 59.4 (9.7) | 29.5 (0.3) | 499 (15.2%) | 836 (25.8%) | 140.4 (18.0) | 83.9 (10.8) | 211.6 (35.4) | 151 (109–207) | 9.8 (2.9) | 32,151 | 273 | 8.5 (7.5–9.6) |
≥30.0 | 4,640 | 1,004 (21.6%) | 58.5 (9.9) | 31.9 (1.9) | 695 (15.0%) | 1,019 (22.2%) | 142.5 (18.5) | 85.6 (11.5) | 214.0 (37.0) | 155 (110–218) | 9.8 (3.0) | 45,459 | 439 | 9.7 (8.8–10.6) |
Total | 179,987 | 68,282 (38.2%) | 58.7 (10.3) | 23.3 (3.1) | 41,104 (22.8%) | 61,107 (34.2%) | 133.1 (18.9) | 79.0 (11.2) | 201.3 (36.1) | 113 (80–164) | 9.9 (3.1) | 1,773,481 | 17,166 | 9.7 (9.5–9.8) |
BMI, body mass index; DBP, diastolic blood pressure; SBP, systolic blood pressure; TC, total cholesterol; TG, triglycerides.
Data are presented as mean (standard deviation), median (interquartile range) or as a number (%).
Follow-up period is presented as mean (standard deviation).
Crude death rates are presented with 95% confidence intervals.